Mental Health Pathway

Size: px
Start display at page:

Download "Mental Health Pathway"

Transcription

1 Mental Health Pathway Triggers for Mental Health Pathway Information for professionals Consider mainstream Mental Health Services (Green light Toolkit) Clinical Interface Protocol Clinical Assessment Information for service users/carers DIAGNOSIS Anxiety Obsessive Compulsive Disorder Depression Bipolar Disorder Psychosis Plan interventions/organise treatment goals Agree expected outcomes with patients and carers Consider other MDT involvement to facilitate outcomes MANAGEMENT/ TREATMENT Anxiety OCD Depression Bipolar Disorder Psychosis Significant Reduction in Symptoms No Significant Reduction in Symptoms Treatment resistance protocols Consider in patient assessment REVIEW Monitor improvement Monitor for side effects Promote recovery Enable rehabilitation Discharge Plan

2 Triggers HONOS-LD items to consider as triggers for discussion whether mental health assessment needed Anxieties/phobias/obsessive compulsive behaviour (score 2) Behaviour(s) sufficiently frequent and severe to produce some disruption of and impact on own or other people s functioning Problems with hallucinations or delusions (score 1) Occasional odd or eccentric beliefs or behaviours suggestive of hallucinations or delusions Problems associated with mood changes (score 2) Mood change producing significant impact on self or others (e.g. weeping spells, decrease in skills, withdrawal and loss of interest

3 Information for Professionals People with Learning Disability are likely to have a higher prevalence of mental health problems. Mental health problems are complex in presentation and can present a diagnostic challenge. Therefore, people with Learning Disability are more likely to have unmet mental health needs. Some flexibility is advised with the assessment approach, in that the assessment may need to be done over a period of time (rather than in one setting) and information from carers is very valuable. Caution is advised with diagnoses especially when there are other issues such as diagnostic overshadowing, cognitive distortion in difficult life situations and when there are symptoms related to other developmental disorders. Specific information for the following disorders: Anxiety Obsessive compulsive disorder Depression Bipolar disorder Psychosis

4 Information for Service Users and Carers Depression Leaflet Anxiety Leaflet Psychosis Leaflet Bipolar Disorder Leaflet

5 Clinical Assessment Full Psychiatric History Developmental History History of Presenting Illness Consider Co-morbid Illnesses Past Psychiatric History Past Treatment History (Consider Side Effects of Medications) Significant Medical History Family History Drugs and Alcohol Relationship History Forensic History Full MSE Investigations (For baseline and to monitor for side effects of medications) Full Blood Count Vitamin B12 Thyroid Functions Liver Functions U&Es

6 DRAFT last updated 01 July 2010 LEARNING DISABILITY AND MENTAL HEALTH SERVICES CLINICAL INTERFACE PROTCOL BETWEEN ADULT MENTAL HEALTH SERVICES AND LEARNING DISABILITY SERVICES 1. INTRODUCTION 1.1 This Clinical Interface Protocol has been jointly developed and agreed between Adult Mental Health Services and Learning Disability Services. The fundamental principles are to direct resources as appropriate to the mental health needs of adults with a learning disability. The protocols are set in the context of: - Valuing People A New Strategy for Learning Disability for the 21st Century Valuing People Now New Horizons: a shared vision for mental health (2009) 2. CONTEXT 2.1 The White Papers (Valuing People (2001) and Valuing People Now (2009) emphasises that mainstream services should be accessed for people who have a learning disability in the same way as the rest of the population. In particular it makes reference to the mental health needs of people with a learning disability. 2.2 The NSF for Mental Health and New Horizons (2009) apply to all adults of a working age. 2.3 A key aspect of the White Paper relates to the importance of close collaboration between Adult Mental Health Services and Learning Disability Services with the provisions of clear protocols outlining joint working. It also states that each local service should have access to an assessment and treatment resource for people with significant learning disability and mental health needs who cannot be appropriately admitted to general psychiatric wards, even with the provision of specialist learning disability support. 3. CURRENT POSITION 3.1 Learning Disability Service (LD Service) is one of the five business units in the Leicestershire Partnership NHS Trust. The LD community service is being redesigned using care pathway model to work in collaboration with other services such as adult mental health service, mental health services for older people, social service, voluntary sector etc. There are eight clinical care pathways identified one which is mental health care pathway. Mental health care pathway is based on a stepped care model which emphasises both the health facilitation of people with LD (supporting people with LD to access mainstream services) as well as providing direct intervention to those with most complex needs. Agnes unit is a 20 bedded inpatient unit providing 12 assessment and treatment beds and 8 step down beds. 3.2 Developments in Adult Mental Health Services to support people with learning disability and mental health problems: - DRAFT last updated 01 July 2010 Acute Mental Health Inpatient Reprovision Project (AMHIRP) includes inpatient provision for people with mild learning disabilities. Mental Health Improvement Partnership (MHIP) includes service redesign to provide mental health services for people with learning disabilities. Forensic Services case-by-case agreement on joint assessment and joint working. 3.2 There is now a requirement for the development of joint protocols to underpin the joint working.

7 DRAFT last updated 01 July 2010 Clinical Interface Protocol Between Adult Mental Health Services and Learning Disability Services 1. PRINCIPLES 1.1 All service users should be treated by the service which best suits their needs. 1.2 The determination as to which service best suits their needs should be ascertained through the application of this Clinical Interface Protocol and mental health care pathway for people with LD. 1.3 On occasion the needs of a service user referred to one of the services may mean that they require transfer to the other. Any passing on of a referral from a Learning Disability service to an Adult Mental Health Service and vice versa should be done with a minimum of disruption and upset to the service user involved with careful planning and discussion between the teams. The original receiver of a referral takes responsibility for the initial assessment and instigates the process to transfer the care. Any decisions made in regard to which service would best meet the service user needs should be conducted in a way that is least disruptive to the patient and their carers and also to the referrer which would often be the General Practitioner. 1.4 Any transfer or support between services should be arranged in accordance with this Clinical Interface Protocol where possible during normal working hours unless there is good justification to do otherwise. 1.5 Joint assessments will usually determine complex issues of who should treat and where. Any joint assessments should be planned in a person-centred manner which meets the needs of the service user and utilises the skills and services available within both Learning Disability and Adult Mental Health services. 1.6 Emergency referrals i.e. those out of hours should adhere to the same principles in this Clinical Interface Protocols as first entry to services. 1.8 This Clinical Interface Protocol will require regular monitoring and audit to evaluate and respond to local and national policy, practice guidelines and the needs and views of service users and carers. Any review would be undertaken jointly by both services. 2. GUIDANCE ON ASSESSING NEED 2.1 The accessibility criteria for people with learning disability and mental health problems should be based on needs rather than an artificial divide of IQ. It is assumed that those with reasonable verbal skills who are able to communicate their needs effectively along with good adaptive behaviour skills (including having the ability to care for self and maintain self-hygiene) should be able to access generic mental health services. It is also important to ensure, at least initially, that none of these individuals suffer from significant sensory or motor impairment, i.e. they should be reasonably mobile and should not have high dependency needs. The caveat may be that some of the skills highlighted above may be temporarily affected due to active mental health problems, i.e. regression in skills usually seen in depressive illness. Should this be the case and there is a risk of exploitation or harm to this person accessing generic inpatient settings, then support should be provided for them to access generic services through health workers and

8 Consultants from the Learning Disability Service. 2.2 Anyone with very limited communication skills (i.e. verbal ability limited to use of few words and inability to speak in sentences) along with significant sensory/motor DRAFT last updated 01 July impairment (mobility restricted to 50 yards or wheelchair-bound) and dependency needs for care should be accessing specialist learning disability service for their mental health problems. 2.3 Conversely, those with Mild Learning Disability, pervasive development disorders and mental health problems whose needs may be more of a maintenance of routine, structure, boundaries and clear communication strategies, may benefit from accessing Learning Disability Services. 2.4 It is imperative that staff working in a generic mental health setting should be trained to identify and manage the potential risks of abuse and exploitation of patients with learning disability in the generic setting. 3. STARTING THE INTERFACE CRITERIA 3.1 The team within the service who initially receive the referral will process that referral as usual, undertaking an initial screening of the referral and assessment. 3.2 The team will hold the case and progress with it as much as possible unless there is a decision made that a joint assessment may be necessary. 3.3 Referrals will not be redirected back to the referrer where there is a debate as to which service would best meet the service user s needs. It is the responsibility of the initial receiving team to follow the Clinical Interface Protocol 3.4 If the receiving team deem that their service is not the most appropriate, that team will initiate local discussion between the other service to discuss the referral. This local discussion can take a number of formats. In the main it is likely to be a clinician to clinician discussion over the telephone. This is likely to be the most successful and will hopefully speed up response rate to progress the referral further. 3.5 This local discussion between services may result in three pathways for the service user: 1) After the initial discussion, the service who initially received the referral (first service) agrees to provide the care. It would then proceed in the normal manner. 2) The referral is passed onto the second service by agreement and that service then takes the lead and responsibility in managing the referral. 3) After the initial discussion, an agreement is made that a joint assessment is required. The outcome of the joint assessment would then be discussed at a multi-disciplinary meeting. This may then result in a number of other options: That one service accepts the referral and proceeds as normal Joint working is agreed. However it is important for one service will have responsibility for leading the joint working (providing care coordination). If there continues to be a disagreement as to who should take the lead and provide the service then this would have to be forwarded to a DRAFT last updated 01 July Dispute Resolution Panel (clinical directors and locality general managers of both services). 4) The final pathway for referral is that the referral is deemed not appropriate for either service and is required to be passed on to services outside the Partnership Trust, such as the voluntary sector or primary care.

9 4. REFERRAL PATHWAYS 4.1 Non urgent referral: Please see Appendix Urgent Referrals for potential Interface patients to Adult Mental Health and Learning Disability Services Urgent referral Local discussion between Adult Mental Health Services and Learning Disability Services Insufficient information to make an informed decision Admission or other intervention agreed and which team to lead Refer to Crisis Resolution Learning Disability Outreach Remain at home with agreement for the following day OR Joint assessment Joint working An urgent referral is received by the service. As with the first entry to service, it is the responsibility of the receiving team to screen the referral and initiate any local discussion between other services if it is deemed necessary Local discussion takes place between the Adult Mental Health service and Learning Disability services which is likely to be through clinicians In the event of this being an urgent referral and out of hours, this would need to take into account on-call arrangements. Following the local discussion a number of options may present themselves: The local discussion has not resolved which service would best meet the needs; therefore a joint assessment is required. The joint assessment is undertaken and the options to progress further are as those in the first entry to service i.e. one service accepts the referral, there is joint working with one service leading or referral onto a service outside of the Trust. There is an agreement that the patient needs admitting and a decision is made between the services as to which service is to lead this process. If admission is required the site based Consultant team provide care, joint working should be considered. Referral to Crisis Resolution or Learning Disability Outreach service

10 OR There may also be the opportunity for joint working between Crisis Resolution and Learning Disability Outreach services. Responsibility for leading this would be with one service There is joint agreement at local discussion that the patient can be discharged home with agreement as to how to follow up the next day. Where possible all supporting information should be available to the receiving service. It is the responsibility therefore for the referral to be screened and that information gathered as much as possible by the first service which receives the referral. If the patient is seen by Crisis Resolution or the Learning Disability Outreach service, it does not automatically mean that other aspects of joint working should cease. 4.3 The majority of people with a dual diagnosis of learning disability and mental health problems are to be enabled to use Adult Mental Health Services, with the support of Learning Disability Services and should have their needs assessment in the most appropriate setting community or hospital. 4.4 Admission into adult mental health in-patient/ward areas should only be considered when there is an acute clinical need requiring assessment and/or treatment and they cannot be safely managed and treated elsewhere in the community. DRAFT last updated 01 July ARBITRATION PROCESS 5.1 If, having followed this Clinical Interface Protocol, there is still dispute between the services as to which service would best meet the needs; the process will be to defer to the Dispute Resolution Panel. The panel would comprise of clinical directors and general managers from both the services who would hear all the information that had been gathered and then use the opportunity to make a decision with representatives from the services as to which would be the best outcome for the individual. 6. REVIEW OF THE PROTOCOL 6.1 This Clinical Interface Protocol will be audited and reviewed by representatives of the Learning Disability services and Adult Mental Health services within six months of its instigation.

11 Anxiety diagnosis (ICD-10 ) Generalized Anxiety Disorder Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is "free-floating"). The dominant symptoms are variable but include complaints of persistent nervousness, trembling, muscular tensions, sweating, lightheadedness, palpitations, dizziness, and epigastric discomfort. Fears that the patient or a relative will shortly become ill or have an accident are often expressed. Panic Disorder [Episodic Paroxysmal Anxiety] The essential feature is recurrent attacks of severe anxiety (panic), which are not restricted to any particular situation or set of circumstances and are therefore unpredictable. As with other anxiety disorders, the dominant symptoms include sudden onset of palpitations, chest pain, choking sensations, dizziness, and feelings of unreality (depersonalization or derealization). There is often also a secondary fear of dying, losing control, or going mad. Panic disorder should not be given as the main diagnosis if the patient has a depressive disorder at the time the attacks start; in these circumstances the panic attacks are probably secondary to depression. Social Phobias Fear of scrutiny by other people leading to avoidance of social situations. More pervasive social phobias are usually associated with low self-esteem and fear of criticism. They may present as a complaint of blushing, hand tremor, nausea, or urgency of micturition, the patient sometimes being convinced that one of these secondary manifestations of their anxiety is the primary problem. Symptoms may progress to panic attacks. Agoraphobia A fairly well-defined cluster of phobias embracing fears of leaving home, entering shops, crowds and public places, or travelling alone in trains, buses or planes. Panic disorder is a frequent feature of both present and past episodes. Depressive and obsessional symptoms and social phobias are also commonly present as subsidiary features. Avoidance of the phobic situation is often prominent, and some agoraphobics experience little anxiety because they are able to avoid their phobic situations.

12 OCD Diagnosis (ICD-10) The essential feature is recurrent obsessional thoughts or compulsive acts. Obsessional thoughts are ideas, images, or impulses that enter the patient's mind again and again in a stereotyped form. They are almost invariably distressing and the patient often tries, unsuccessfully, to resist them. They are, however, recognized as his or her own thoughts, even though they are involuntary and often repugnant. Compulsive acts or rituals are stereotyped behaviours that are repeated again and again. They are not inherently enjoyable, nor do they result in the completion of inherently useful tasks. Their function is to prevent some objectively unlikely event, often involving harm to or caused by the patient, which he or she fears might otherwise occur. Usually, this behaviour is recognized by the patient as pointless or ineffectual and repeated attempts are made to resist. Anxiety is almost invariably present. If compulsive acts are resisted the anxiety gets worse.

13 Depression Diagnosis Depressive Episode In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tiredness after even minimum effort is common. Sleep is usually disturbed and appetite diminished. Self-esteem and selfconfidence are almost always reduced and, even in the mild form, some ideas of guilt or worthlessness are often present. The lowered mood varies little from day to day, is unresponsive to circumstances and may be accompanied by so-called "somatic" symptoms, such as loss of interest and pleasurable feelings, waking in the morning several hours before the usual time, depression worst in the morning, marked psychomotor retardation, agitation, loss of appetite, weight loss, and loss of libido. Depending upon the number and severity of the symptoms, a depressive episode may be specified as mild, moderate or severe. Mild Depressive Episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities. Moderate Depressive Episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities. Page 1 of 2

14 Severe Depressive Episode Without Psychotic Symptoms An episode of depression in which several of the above symptoms are marked and distressing, typically loss of self-esteem and ideas of worthlessness or guilt. Suicidal thoughts and acts are common and a number of "somatic" symptoms are usually present. Severe Depressive Episode With Psychotic Symptoms An episode of depression as described in F32.2, but with the presence of hallucinations, delusions, psychomotor retardation, or stupor so severe that ordinary social activities are impossible; there may be danger to life from suicide, dehydration, or starvation. The hallucinations and delusions may or may not be mood-congruent. Recurrent Depressive Disorder A disorder characterized by repeated episodes of depression as described for depressive episode (F32.-), without any history of independent episodes of mood elevation and increased energy (mania). There may, however, be brief episodes of mild mood elevation and overactivity (hypomania) immediately after a depressive episode, sometimes precipitated by antidepressant treatment. The more severe forms of recurrent depressive disorder (F33.2 and F33.3) have much in common with earlier concepts such as manic-depressive depression, melancholia, vital depression and endogenous depression. The first episode may occur at any age from childhood to old age, the onset may be either acute or insidious, and the duration varies from a few weeks to many months. The risk that a patient with recurrent depressive disorder will have an episode of mania never disappears completely, however many depressive episodes have been experienced. If such an episode does occur, the diagnosis should be changed to bipolar affective disorder (F31.-). Page 2 of 2

15 Bipolar Disorder Diagnosis Bipolar Affective Disorder A disorder characterized by two or more episodes in which the patient's mood and activity levels are significantly disturbed, this disturbance consisting on some occasions of an elevation of mood and increased energy and activity (hypomania or mania) and on others of a lowering of mood and decreased energy and activity (depression). Repeated episodes of hypomania or mania only are classified as bipolar. Bipolar Affective Disorder, Current Episode Hypomanic The patient is currently hypomanic, and has had at least one other affective episode (hypomanic, manic, depressive, or mixed) in the past. Bipolar Affective Disorder, Current Episode Manic Without Psychotic Symptoms The patient is currently manic, without psychotic symptoms (as in F30.1), and has had at least one other affective episode (hypomanic, manic, depressive, or mixed) in the past. Bipolar Affective Disorder, Current Episode Manic With Psychotic Symptoms The patient is currently manic, with psychotic symptoms (as in F30.2), and has had at least one other affective episode (hypomanic, manic, depressive, or mixed) in the past. Bipolar Affective Disorder, Current Episode Mild Or Moderate Depression The patient is currently depressed, as in a depressive episode of either mild or moderate severity (F32.0 or F32.1), and has had at least one authenticated hypomanic, manic, or mixed affective episode in the past. Page 1 of 2

16 Bipolar Affective Disorder, Current Episode Severe Depression Without Psychotic Symptoms The patient is currently depressed, as in severe depressive episode without psychotic symptoms (F32.2), and has had at least one authenticated hypomanic, manic, or mixed affective episode in the past. Bipolar Affective Disorder, Current Episode Severe Depression With Psychotic Symptoms The patient is currently depressed, as in severe depressive episode with psychotic symptoms (F32.3), and has had at least one authenticated hypomanic, manic, or mixed affective episode in the past. Bipolar Affective Disorder, Current Episode Mixed The patient has had at least one authenticated hypomanic, manic, depressive, or mixed affective episode in the past, and currently exhibits either a mixture or a rapid alteration of manic and depressive symptoms. Bipolar Affective Disorder, Currently In Remission The patient has had at least one authenticated hypomanic, manic, or mixed affective episode in the past, and at least one other affective episode (hypomanic, manic, depressive, or mixed) in addition, but is not currently suffering from any significant mood disturbance, and has not done so for several months. Periods of remission during prophylactic treatment should be coded here. Page 2 of 2

17 Psychosis Diagnosis Schizophrenia The schizophrenic disorders are characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted. Clear consciousness and intellectual capacity are usually maintained although certain cognitive deficits may evolve in the course of time. The most important psychopathological phenomena include thought echo; thought insertion or withdrawal; thought broadcasting; delusional perception and delusions of control; influence or passivity; hallucinatory voices commenting or discussing the patient in the third person; thought disorders and negative symptoms. The course of schizophrenic disorders can be either continuous, or episodic with progressive or stable deficit, or there can be one or more episodes with complete or incomplete remission. The diagnosis of schizophrenia should not be made in the presence of extensive depressive or manic symptoms unless it is clear that schizophrenic symptoms antedate the affective disturbance. Nor should schizophrenia be diagnosed in the presence of overt brain disease or during states of drug intoxication or withdrawal. Similar disorders developing in the presence of epilepsy or other brain disease should be classified under F06.2, and those induced by psychoactive substances under F10-F19 with common fourth character.5.

18 Anxiety Management and Treatment Broad Approach To Treatment In Anxiety Disorders Consider the full range of possible co-morbidities when planning treatment Actively consider psychological approaches to treatment When making a decision about the first line of treatment (talking therapies or medication), consider severity of illness, distress and impairment in functioning. The duration of waiting to uptake a talking therapy would also be significant Acute Phase Of Treatment Agree with service user/carers on treatment goals Offer appropriate doses as per guidelines to achieve a significant reduction in symptoms Once reduction in symptoms is achieved, move to maintenance phase Maintenance Phase Of Treatment Focus on maintaining improvement Review dose of medication to maintenance phase Psychoeducation Return to baseline level of functioning Anxiety Management and Treatment Guidelines for Treatment with Medication The Frith algorithms Panic Disorder Generalised Anxiety Disorder NICE Guidelines

19 Panic disorders Algorithm 15.2 Treatment of panic disorders in adults with LD Try cognitive behaviour therapy or anxiety management Continue treatment Partial or poor response Try an SSRI or SNRI eg paroxetine, sertaline, escitalopram or venlafaxine Continue treatment Partial or poor response Try imipramine Continue treatment Partial or poor response Try propranolol Continue treatment Partial or poor response Try benzodiazepines Continue treatment but limit to 4 weeks

20 Algorithm 15.3 Treatment of generalised anxiety disorder in adults with LD Generalised anxiety disorder Cognitive behavioural therapy or anxiety management training where applicable continue Poor or partial response Predominantly somatic symptoms Minimal somatic symptoms Propranolol up to 120mg/day [Note 1] Poor response or side effects Continue treatment Stop propanolol Start an SSRI (preferably with a long half-life) or venlafaxine or pregabalin Poor response Continue treatment [Note 3] Try another SSRI or a tricyclic antidepressant or a small dose of antipsychotc or buspirone or a benzodiazepine [Note 2]

21 OCD Management and Treatment Broad Approach To Treatment In OCD Consider the full range of possible co-morbidities when planning treatment. Consider pervasive developmental disorders in the differential diagnosis, or as a co-morbidity. Actively consider psychological approaches to treatment When making a decision about the first line of treatment (talking therapies or medication), consider severity of illness, distress and impairment in functioning. The duration of waiting to uptake a talking therapy would also be significant Acute Phase Of Treatment Agree with service user/carers on treatment goals Offer appropriate doses as per guidelines to achieve a significant reduction in symptoms Once reduction in symptoms is achieved, move to maintenance phase Consider exposure response prevention as part of the CBT approach. Maintenance Phase Of Treatment Focus on maintaining improvement Review dose of medication to maintenance phase Psychoeducation Return to baseline level of functioning Guidelines for Treatment with Medication o o The Frith Algorithms NICE Guidelines

22 Algorithm 15.1 Treatment of obsessive compulsive disorder (OCD) in adults with LD OCD Not associated with autistic spectrum disorder Associated with autistic spectrum disorder Try psychological approaches Try psychological approaches Poor response Poor response Continue treatment Try an antidepressant eg paroxetine or fluoxetine or sertraline a high dose if required upto BNF limits Try a small dose of antipsychotic eg haloperidol or risperidone or olanzapine Continue treatment Poor response or side effects Withdraw antipsychotic Try high dose of antidepressant if required upto BNF limits eg paroxetine or fluoxetine or sertraline or clomipramine Continue treatment Poor response or side effects Try a combination of small doses of an atypical antipsychotic and SSRI eg risperidone and paroxetine Continue treatment

23 Depression Management and Treatment Broad Approach To Treatment In Depressive Disorders Consider the full range of possible co-morbidities when planning treatment Actively consider psychological approaches to treatment When making a decision about the first line of treatment (talking therapies or medication), consider severity of illness, distress and impairment in functioning. The duration of waiting to uptake a talking therapy would also be significant Consider whether part of a recurrent depressive disorder or bipolar disorder Acute Phase Of Treatment Agree with service user/carers on treatment goals Offer appropriate doses as per guidelines to achieve a significant reduction in symptoms Once reduction in symptoms is achieved, move to maintenance phase Maintenance Phase Of Treatment Focus on maintaining improvement Review dose of medication to maintenance phase Consider prophylaxis if recurrent depression or bipolar disorder Psychoeducation Return to baseline level of functioning Guidelines for Treatment with Medication The Frith Algorithms NICE Guidelines

24 Algorithm 17.1 Treatment of depression in adults with LD Depression [Note 1] Try a tricyclic antidepressant if previous history of successful treatment with this medication Severe psychotic depression or serious suicide risk. Consider ECT with concomitant antidepressant treatment ± antipsychotic Newer antidepressants eg SSRIs at therapeutic dose or for at least 4 weeks Effective, well tolerated Ineffective Ineffective Continue treatment for 6-9 months if first episode; 2-5 years if recurrent Increase dose. Re-assess after 4 weeks Review diagnosis Change antidepressant Change antidepressant consider SNRIs, NARIs, or a NASSA Ineffective, poorly tolerated Continue treatment for 6-9 months if first episode; 2-5 years if recurrent Effective, well tolerated Ineffective, poorly tolerated Change class of antidepressant Ineffective, poorly tolerated Consider lithium augmentation or ECT Monitor thyroid function tests 6-9 months Effective, well tolerated Effective Ineffective, poorly tolerated Augmentation with T3 Try reversible MAOIs [Note 2] Ineffective Effective, well tolerat Maintain dietary restric Ineffective Putative treatments [Note 3]

25 Bipolar Disorder Management and Treatment Broad Approach To Treatment In Bpad Consider whether part of a recurrent depressive disorder or bipolar disorder. Due consideration to prophylaxis Acute Phase Of Treatment Agree with service user/carers on treatment goals Offer appropriate doses as per guidelines to achieve a significant reduction in symptoms Once reduction in symptoms is achieved, move to maintenance phase Maintenance Phase Of Treatment Focus on maintaining improvement Review dose of medication to maintenance phase. Psychoeducation Return to baseline level of functioning Guidelines for Treatment with Medication The Frith Algorithms NICE Guidelines

26 Algorithm 17.3 Treatment of mania/hypomania associated with bipolar affective disorder in adults with LD Rapid tranquillisation [Note 8] Commence antimanic medication, one of the following eg olanzapine, quetiapine, divalproex sodium, sodium valproate, carbamazepine or risperidone [Note 2] Poor response Continue mood stabiliser. In not alr on one consider prophylaxis with lit or carbamazepine or sodium valpr [Notes 3,4,5,6] With aggression Poor response/not on lithium or other mood stabiliser Add benzodiazepine [Note 7] Mania/hypomania Continue Poor response Without aggression If already on lithium/other mood stabiliser augment the dose if permissible [Note 1] Commence mood stabiliser/ antipsychotic if not already started Attempt to withdraw antipsychotic drug Poor response Consider combination of mood stabilisers eg lithium+sodium valproate+/-antipsychotic drug Continue Consider other drugs such as clozapine, lamotrigine or topiramate NB Committee on Safety in Medicine warning

27 Psychosis Management and Treatment Broad Approach To Treatment In Psychotic Disorders Focus on containing risks Consider joint working with teams like PIER Acute Phase Of Treatment Agree with service user/carers on treatment goals Offer appropriate doses as per guidelines to achieve a significant reduction in symptoms Once reduction in symptoms is achieved, move to maintenance phase Maintenance Phase Of Treatment Focus on maintaining improvement Review dose of medication to maintenance phase. Psychoeducation Return to baseline level of functioning Guidelines for Treatment with Medication The Frith Algorithms NICE Guidelines

28 Algorithm 18.1 Drug treatment of schizophrenia and other psychotic disorders in adults with LD Tolerated but ineffective. Positive/negative symptoms Atypical emerge/persist. antipsychotic [Note 2] Poorly tolerated and ineffective Poorly tolerated but effective Within BNF limits Outside BNF limits Ineffective and/or Ineffective poorly tolerated Consider another Ineffective/poor Is the patient on class of atypical tolerance typical antipsychotic Effective, continue antipsychotics? treatment Maximise dose (If the patient is antipsychotic within naïve BNF or if limits a new assessment see below try an atypical antipsychotic as first choice and skip to appropriate step in this algorithm.) Tolerated Effective but poorly tolerated Atypical antipsychotic [Note 2] Titrate dose of anticholinergic [Note 3] Effective and well tolerated Consider dose titration and anticholinergics Effective Explain and long-term side effects to patients and relatives; document such in notes. Continue well tolerated Follow advice of RCP in BNF [Note 1] eg ECG where possible and repeat periodically; document and discuss if ECG not possible If side effects persist If side effects improve Continue treatment Poorly tolerated Consider drug resistance Try clozapine Continue treatment [Note 9] Change atypical antipsychotic Effective, conti [Not Ineffective Consider augmentation [Note 7] Acute aggression or violence First diagnosis or antipsychotic- naive Consider Non-pharmacological rapid tranquillisation with a typical or an interventions atypical antipsychotic (lorazepam Atypical IM/oral) antipsychotic [Note 6] [Note 5] For a new diagnosis or for the first episode of schizophrenia NICE guidance recommends a trial of an atypical antipsychotic as being preferable to a typical antipsychotic No aggression Atypical antipsychotic [Note 4] Typical or atypical antipsychotic antipsychotic- naive [Note 8] New patient who may/may not be NB Committee on Safety in Medicine warning

29 Approach to Treatment Resistant Conditions o o o o o Review history Review diagnosis Review doses of medication Review compliance to treatment Consider undiagnosed co-morbidites Review investigations: consider neuro-imaging Consider exploring for other developmental disorders o o o Consider influence of environmental factors Consider other classes of drugs, augmentation strategies Consider a period of assessment in the inpatient unit

30 Discharge Planning Ensure global outcomes achieved Agree on discharge with service user/carer Letter to GP Reason for referral Outcome of assessment Outcome of intervention Advice on management of condition in primary care Advice on early symptoms/signs of recurrence Advice on re-referral

Mental Health Pathway

Mental Health Pathway Mental Health Pathway Triggers for Mental Health Pathway Information for professionals Consider mainstream Mental Health Services (Green light Toolkit) Clinical Interface Protocol Clinical Assessment Information

More information

MENTAL HEALTH CARE PATHWAY

MENTAL HEALTH CARE PATHWAY MENTAL HEALTH CARE PATHWAY Information for professionals Information for service users/carers Referral received identifying mental health issues Consider mainstream Mental Health Services (Green light

More information

Aiming for recovery for patients with severe or persistent depression a view from secondary care. Chrisvan Koen

Aiming for recovery for patients with severe or persistent depression a view from secondary care. Chrisvan Koen Aiming for recovery for patients with severe or persistent depression a view from secondary care Chrisvan Koen Kent and Medway NHS and Social care Partnership trust Persistent depressive disorder F34 Persistent

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

Mental illness A Broad Overview. Dr H Pathmanandam March 2017 Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate

More information

The treatment of bipolar disorder in adults, children and adolescents

The treatment of bipolar disorder in adults, children and adolescents DRAFT FOR CONSULTATION The treatment of bipolar disorder in adults, children and adolescents The paragraphs in the draft are numbered for the purposes of consultation. The final version will not contain

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST. Referral Criteria for Specialist Tier 3 CAMHS

HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST. Referral Criteria for Specialist Tier 3 CAMHS Referral Criteria for Specialist Tier 3 CAMHS Specialist CAMHS provides mental health support, advice and guidance and treatment for Children and Young People with moderate or severe mental health difficulties,

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

Affective Disorders.

Affective Disorders. Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

Pharmacological Treatment of Anxiety & Depressive Disorders

Pharmacological Treatment of Anxiety & Depressive Disorders Pharmacological Treatment of Anxiety & Depressive Disorders Dr Gary Jackson (MB BCh FRCPsych) Consultant Psychiatrist The Priory Hospital Chelmsford Wellesley Hospital Southend-on-Sea Medical Secretary:

More information

BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0)

BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) General information The Bipolar Affective Disorder Dimension Scale (BADDS) has been developed in order to address

More information

Jonathan Haverkampf BIPOLAR DISORDR BIPOLAR DISORDER. Dr. Jonathan Haverkampf, M.D.

Jonathan Haverkampf BIPOLAR DISORDR BIPOLAR DISORDER. Dr. Jonathan Haverkampf, M.D. BIPOLAR DISORDER Dr., M.D. Abstract - Bipolar disorder is a condition affecting an individual s affective states (mood). The different flavors of bipolar disorder have in common that there are alterations

More information

Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines Formulary and Prescribing Guidelines SECTION 3: TREATMENT OF BIPOLAR AFFECTIVE DISORDER This section provides information regarding the pharmacological management of Bipolar affective disorder in secondary

More information

Anxiety Disorders. Dr Simon Christopherson Dr Alison Macrae

Anxiety Disorders. Dr Simon Christopherson Dr Alison Macrae Anxiety Disorders Dr Simon Christopherson Dr Alison Macrae 1 What is anxiety? Universal fight or flight experience Nerves / fearfulness can boost performance Worries keep you alert & prevent you missing

More information

Bipolar and Affective Disorders. Harleen Johal

Bipolar and Affective Disorders. Harleen Johal + Bipolar and Affective Disorders Harleen Johal hkj1g11@soton.ac.uk + Affective (mood) disorders n Depression n Bipolar disorder n Anxiety n Treatment + Depression: Definition n Pervasiveand persistent

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

Referral guidance for Lincolnshire CAMHS

Referral guidance for Lincolnshire CAMHS Referral guidance for Lincolnshire CAMHS The service is designed to meet a wide range of mental health needs in children and young people. This includes mild to moderate emotional wellbeing and mental

More information

Depression in adults: treatment and management

Depression in adults: treatment and management 1 2 3 4 Depression in adults: treatment and management 5 6 7 8 Appendix V3: recommendations that have been deleted of changed from 2009 guideline Depression in adults: Appendix V3 1 of 22 1 Recommendations

More information

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions

More information

Brief Notes on the Mental Health of Children and Adolescents

Brief Notes on the Mental Health of Children and Adolescents Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

Some newer, investigational approaches to treating refractory major depression are being used.

Some newer, investigational approaches to treating refractory major depression are being used. CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular

More information

DISEASES AND DISORDERS

DISEASES AND DISORDERS DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related

More information

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT

More information

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP GREATER MANCHESTER INTERFACE PRESCRIBING GROUP On behalf of the GREATER MANCHESTER MEDICINES MANAGEMENT GROUP SHARED CARE GUIDELINE FOR THE PRESCRIBING OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)

More information

When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation

When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference Goals for presentation *To review DSM-V criteria for some of the most frequently

More information

DSM5: How to Understand It and How to Help

DSM5: How to Understand It and How to Help DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental

More information

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned

More information

Understanding Psychiatry & Mental Illness

Understanding Psychiatry & Mental Illness Understanding Psychiatry & Steve Ellen Mental Illness MB, BS. M.Med. MD. FRANZCP Head, Consultation, Liaison & Emergency Psychiatry, Alfred Health. Associate Professor, Monash Alfred Psychiatry Research

More information

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder

More information

DIAGNOSTIC CRITERIA (ICD 10)

DIAGNOSTIC CRITERIA (ICD 10) DEPRESSION Depression is a major public health problem around the world Affects 1:5 older people living in the community Affects 2:5 older people living in care homes Various treatment options available,

More information

Depression Workshop 26 January 2007

Depression Workshop 26 January 2007 Depression Workshop 26 January 2007 Leslie G Walker Professor of Cancer Rehabilitation Donald M Sharp Senior Lecturer in Behavioural Oncology Mary B Walker Senior Clinical and Research Nurse Specialist

More information

Document Title Pharmacological Management of Generalised Anxiety Disorder

Document Title Pharmacological Management of Generalised Anxiety Disorder Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder: Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now

More information

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on

More information

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson Psychotropic Drug Therapy in Adults with Learning Disability Steve Wilkinson Outline and Aims of the Session Drug use in learning disability Two distinct areas of drug therapy I. Treatment of common psychiatric

More information

Some Common Mental Disorders in Young People Module 3B

Some Common Mental Disorders in Young People Module 3B Some Common Mental Disorders in Young People Module 3B MENTAL ILLNESS AND TEENS About 70% of all mental illnesses can be diagnosed before 25 years of age When they start, most mental illnesses are mild

More information

4. Definition, clinical diagnosis and diagnostic criteria

4. Definition, clinical diagnosis and diagnostic criteria 4. Definition, clinical diagnosis and diagnostic criteria 4.1. Definition Major depression is a mood disorder consisting of a set of symptoms, which include a predominance of the affective type (pathological

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

D. Exclusion of schizoaffective disorder and mood disorder with psychotic features.

D. Exclusion of schizoaffective disorder and mood disorder with psychotic features. 65 CHAPTER 8: APPENDIX. ADDENDUM A DSM-IV diagnostic criteria for schizophrenia A. Characteristic symptoms: Two or more of the following, each present for a significant portion of time during a one-month

More information

Helping People with Mental Disorders -public forum-

Helping People with Mental Disorders -public forum- Helping People with Mental Disorders -public forum- Dr. ONG BENG KEAT Consultant Psychiatrist Psychological Medicine Clinic LohGuanLye Specialists Centre, Penang AN OVERVIEW Remove the stigma Understanding

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication in the Treatment of Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction The use of medication is but one

More information

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance] SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm

More information

Doncaster Improving Access to Psychological Therapies (IAPT) Nurse Target September 2018 Dennis Convery

Doncaster Improving Access to Psychological Therapies (IAPT) Nurse Target September 2018 Dennis Convery Doncaster Improving Access to Psychological Therapies (IAPT) Nurse Target September 2018 Dennis Convery Aims of the session To introduce the role and function of Doncaster IAPT (improving access to psychological

More information

Your journal: how can it help you?

Your journal: how can it help you? Journal Your journal: how can it help you? By monitoring your mood along with other symptoms like sleep, you and your treatment team will be better able to follow the evolution of your symptoms and therefore

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia

More information

Department of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT

Department of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT Department of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT The purpose of this report is to outline the information needed to make a disability determination. This is not a required format; however,

More information

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,

More information

Anxiety Disorders: First aid and when to refer on

Anxiety Disorders: First aid and when to refer on Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?

More information

Psychology Session 11 Psychological Disorders

Psychology Session 11 Psychological Disorders Psychology Session 11 Psychological Disorders Date: November 18th, 2016 Course instructor: Cherry Chan Mothercraft College Agenda 1. Normal vs. Abnormal 2. Communication disorders 3. Anxiety disorders

More information

Management Of Depression And Anxiety

Management Of Depression And Anxiety Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate

More information

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,

More information

Mental Health Disorders in 22q11 DS

Mental Health Disorders in 22q11 DS Mental Health Disorders in 22q11 DS Give yourself plenty of time to read this leaflet and do get in touch with us if you have any queries or concerns. The purpose of this leaflet is to give you a broad

More information

RDaSH. Referral criteria. Rotherham comprehensive child and adolescent mental health services (CAMHS)

RDaSH. Referral criteria. Rotherham comprehensive child and adolescent mental health services (CAMHS) Referral criteria Rotherham comprehensive child and adolescent mental health services (CAMHS) RDaSH Children and Young People s Mental Health Services Service overview The Rotherham Comprehensive CAMHS

More information

A Basic Approach to Mood and Anxiety Disorders in the Elderly

A Basic Approach to Mood and Anxiety Disorders in the Elderly A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict

More information

A new Anatomy of Melancholy: rethinking depression and resilience

A new Anatomy of Melancholy: rethinking depression and resilience A new Anatomy of Melancholy: rethinking depression and resilience Prof Declan McLoughlin Dept of Psychiatry & Trinity College Institute of Neuroscience Trinity College Dublin St Patrick s University Hospital

More information

Managing Common Mental Health Problems

Managing Common Mental Health Problems Managing Common Mental Health Problems Dr John S Parker MBBCh; FCPsych(SA) Dept of Psychiatry and Mental Health, Faculty of Health Sciences, UCT. Lentegeur Psychiatric Hospital SAMA Conference 2016 Universal

More information

INPATIENT INCLUDED ICD-10 CODES

INPATIENT INCLUDED ICD-10 CODES INPATIENT INCLUDED ICD-10 CODES MHSUDS IN 18-053 ICD-10 F01.51 Vascular Dementia With Behavioral Disturbance F10.14 Alcohol Abuse With Alcohol-Induced Mood Disorder F10.150 Alcohol Abuse With Alcohol-Induced

More information

Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health

Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health Solutions, PLLC www.bartoncbt.com Academic and Pop-Culture

More information

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types

More information

Health of the Nation Outcome Scales 65+ Glossary

Health of the Nation Outcome Scales 65+ Glossary Health of the Nation Outcome Scales 65+ Glossary HoNOS 65+ rating guidelines Rate items in order from 1 to 12. Use all available information in making your rating. Do not include information already rated

More information

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant. 1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number

More information

MENTAL HEALTH DISEASE CLASSIFICATIONS

MENTAL HEALTH DISEASE CLASSIFICATIONS MENTAL HEALTH DISEASE CLASSIFICATIONS DIAGNOSIS OF MENTAL DISORDERS DSM-IV-TR Published by APA ( 2000 ) Multiaxial system 5 categories called axes Facilitate holistic assessment for care Is a great resource

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Personality Disorder: the clinical management of borderline personality disorder 1.1 Short title Borderline personality disorder

More information

Health of the Nation Outcome Scales (HoNOS)

Health of the Nation Outcome Scales (HoNOS) Health of the Nation Outcome Scales (HoNOS) HoNOS rating guidelines Rate items in order from 1 to 12. Use all available information in making your rating. Do not include information already rated in an

More information

Psychotic and Mood Disorders

Psychotic and Mood Disorders Psychotic and Mood Disorders د ر ا ر با ی کلاس د یاران سال اول روا پ ز ش ی وه روا پ ز ش ی دا ه ع وم زپ ش ی ا ان 93/6/16 2 Symptoms Mood Anxious Psychotic Non-specific Depressed mood Anxiety/Worry Delusion

More information

MENTAL HEALTH AND INTELLECTUAL DISABILITY. Presented by The Junction Works Ltd

MENTAL HEALTH AND INTELLECTUAL DISABILITY. Presented by The Junction Works Ltd MENTAL HEALTH AND INTELLECTUAL DISABILITY Presented by The Junction Works Ltd Myth or Reality Questionnaire Sharing knowledge is the best way to overcome preconceptions about mental illness 2 Introduction

More information

Residual Functional Capacity Questionnaire MENTAL IMPAIRMENT

Residual Functional Capacity Questionnaire MENTAL IMPAIRMENT Residual Functional Capacity Questionnaire MENTAL IMPAIRMENT Patient: DOB: Physician completing this form: Please complete the following questions regarding this patient's impairments and attach all supporting

More information

Mood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland

Mood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Mood Disorders Workshop 2010 Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Goals To learn about the clinical presentation of mood

More information

Panic disorder is a chronic and recurrent illness associated

Panic disorder is a chronic and recurrent illness associated CLINICAL PRACTICE GUIDELINES Management of Anxiety Disorders. Panic Disorder, With or Without Agoraphobia Epidemiology Panic disorder is a chronic and recurrent illness associated with significant functional

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Psychosis and schizophrenia in children and young people: recognition and management 1.1 Short title Psychosis and schizophrenia

More information

Manual of Clinical Psychopharmacology

Manual of Clinical Psychopharmacology Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School

More information

Managing Behavioural Problems in Patients with Learning Disabilities

Managing Behavioural Problems in Patients with Learning Disabilities Managing Behavioural Problems in Patients with Learning Disabilities Some people with a learning disability display behaviour that challenges. Although such behaviour is a challenge to services, family

More information

GOALS FOR THE PSCYHIATRY CLERKSHIP

GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice 1 Guideline title SCOPE Autism: the management and support of children and young people on the autism spectrum 1.1 Short

More information

DEPRESSION Depression is a major public health problem around the world Affects 1:5 older people living in the community Affects 2:5 older people living in care homes Various treatment options available,

More information

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and

More information

Depression in children: identification and management of depression in children and young people in primary, community and secondary care

Depression in children: identification and management of depression in children and young people in primary, community and secondary care Depression in children: identification and management of depression in children and young people in primary, community and secondary care NICE guideline First consultation, November 2004 If you wish to

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Personality disorder: the management and prevention of antisocial (dissocial) personality disorder 1.1 Short title Antisocial

More information

ACOEM Commercial Driver Medical Examiner Training Program

ACOEM Commercial Driver Medical Examiner Training Program ACOEM Commercial Driver Medical Examiner Training Program Module 7: Psychological Psychological 49 CFR 391.41(b)(9) "A person is physically qualified to drive a commercial motor vehicle if that person

More information

Schizoaffective Disorder

Schizoaffective Disorder Schizoaffective Disorder This leaflet is designed to help understand schizoaffective disorder. It may be useful if: you have a diagnosis of schizoaffective disorder you are worried that you may have this

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

10. Psychological Disorders & Health

10. Psychological Disorders & Health 10. Psychological Disorders & Health We will now study different psychological disorders and theories for treating psychopathology. We will also cover health, stress and how to cope with them. The sections

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update 1 Guideline title Anxiety: management of generalised anxiety disorder in adults in primary, secondary and community care (update)

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Psychosis with coexisting substance misuse

Psychosis with coexisting substance misuse Psychosis with coexisting substance misuse Assessment and management in adults and young people Issued: March 2011 NICE clinical guideline 120 guidance.nice.org.uk/cg120 NICE has accredited the process

More information

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) E099 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Psychosis and schizophrenia in adults: treatment and management Quality standard title:

More information

Advocating for people with mental health needs and developmental disability GLOSSARY

Advocating for people with mental health needs and developmental disability GLOSSARY Advocating for people with mental health needs and developmental disability GLOSSARY Accrued deficits: The delays or lack of development in emotional, social, academic, or behavioral skills that a child

More information

Psychopathology Psychopathy (con t) Psychopathy Characteristics High impulsivity Thrill seeking Low empathy Low anxiety What is the common factor? Callous Self-Centeredness N M P Dr. Robert Hare

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

ICD 10 CM Codes for Evaluation & Management October 1, 2017

ICD 10 CM Codes for Evaluation & Management October 1, 2017 ICD 10 CM Codes for Evaluation & Management October 1, 2017 Code Description Comments F01.50 Vascular dementia without behavioral disturbance F01.51 Vascular dementia with behavioral disturbance F02.80

More information

Oxleas CAMHS Dr Joanna Sales Clinical Director. Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis

Oxleas CAMHS Dr Joanna Sales Clinical Director. Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis Oxleas CAMHS Dr Joanna Sales Clinical Director Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis PREVALENCE At any one time, the estimated number of children and young

More information

8/23/2016. Chapter 34. Care of the Patient with a Psychiatric Disorder. Care of the Patient with a Psychiatric Disorder

8/23/2016. Chapter 34. Care of the Patient with a Psychiatric Disorder. Care of the Patient with a Psychiatric Disorder Chapter 34 Care of the Patient with a Psychiatric Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Care of the Patient with a Psychiatric

More information

Depression: management of depression in primary and secondary care

Depression: management of depression in primary and secondary care Issue date: December 2004, with amendments April 2007 Quick reference guide (amended) Depression: management of depression in primary and secondary care Amendment of recommendations concerning venlafaxine:

More information

HoNOS. Health of the Nation Outcome Scales. Glossary for HoNOS Score Sheet

HoNOS. Health of the Nation Outcome Scales. Glossary for HoNOS Score Sheet HoNOS Health of the Nation Outcome Scales Glossary for HoNOS Score Sheet Royal College of Psychiatrists 6th Floor, Standon House, 21 Mansell Street, London E1 8AA HoNOS August 1996 Authors: J. K. Wing,

More information